Injective (INJ) is currently priced at $2.88, reflecting a 24-hour decline of 6.07%. The asset has demonstrated a daily range between a low of $2.84 and a high of $3.07, indicating volatility within a narrow band.

Volume over the past 24 hours stands at approximately $42.5 million, representing 14.76% of the market cap, which suggests moderate trading activity. However, the significant drop in price combined with the low hourly RSI of 25 indicates oversold conditions, potentially signaling a turnaround point.

The moving averages show a consistent downtrend, with the 8 SMA at $2.92 and the 55 SMA around $3.05, all reflecting negative percentages. The 7-day RSI at 45, alongside the 7-day price change of -7.18%, further emphasizes the bearish momentum, while the 14-day change of -14.73% and 30-day change of -19.14% reflect ongoing weakness.

Despite the current oversold conditions, the resistance levels indicated by the moving averages suggest that a short-term recovery may face headwinds. The all-time high of $52.62, reached in March 2024, provides a stark contrast to the current price, underscoring the substantial decline from previous peaks.

Considering the current technical indicators and market sentiment, Injective's price action is bearish in the short term, with resistance likely around the moving averages. Given the oversold conditions, a cautious Hold rating is appropriate, allowing for potential recovery while monitoring for further bearish signals.